FARMHOUSE, INC. AND SUBSIDIARY
CONSENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three and six months ended June 30, 2022
(unaudited)

	Common Stock					Accumulated
	Shares	Par Value		Paid-in Capital		Deficit		Total

Balance at December 31, 2021	15,694,550	$	1,570	$	3,729,104	$	(5,301,917)	$	(1,571,243)

Common stock sold	41,300		4		35,101		-		35,105
Common stock issued for services	100,500		10		69,402		-		69,412
Stock-based compensation on RSA's vested	-		-		25,500		-		25,500
Net loss	-		-		-		(234,217)		(234,217)
Balance at March 31, 2022	15,836,350		1,584		3,859,107		(5,536,134)		(1,675,443)

Common stock sold	28,600		3		24,307		-		24,310
Common stock issued for services	93,000		9		120,161		-		120,170
Stock-based compensation on RSA's vested					25,500		-		25,500
Net loss	-		-		-		(256,079)		(256,079)
Balance at June 30, 2022	15,957,950	$	1,596	$	4,029,075	$	(5,792,213)	$	(1,761,542)

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

For the three months ended Sept. 30,

For the nine months ended Sept. 30,
2021

2020

2021

2020

REVENUES

Net revenues
$
            149

$
         5,000

$
       12,045

$
         7,940
Total revenues

            149

         5,000

       12,045

         7,940

OPERATING EXPENSES

General and administrative

        116,234

        107,831

        286,204

        273,928
Professional fees

        132,107

          48,470

        347,544

        161,756
Depreciation and amortization

              295

              397

              883

            1,621
Total operating expenses

        248,636

        156,698

        634,631

        437,305

LOSS FROM OPERATIONS

       (248,487)

       (151,698)

       (622,586)

       (429,365)

OTHER INCOME (EXPENSE):

Recovery of expense in litigation

          22,382

                 -

          22,382

                 -
Gain on extinguishment of debt

          14,220

                 -

          14,220

                 -
Interest expense

        (12,836)

          (2,309)

        (32,229)

        (38,653)
Total other income (expense)

          23,766

          (2,309)

            4,373

        (38,653)

NET LOSS
$
       (224,721)

$
       (154,007)

$
       (618,213)

$
       (468,018)

BASIC AND DILUTED NET LOSS PER SHARE
$
            (0.01)

$
            (0.01)

$
            (0.04)

$
            (0.03)

BASIC AND DILUTED WEIGHTED
AVERAGE NUMBER OF SHARES
OUTSTANDING

   15,337,287

   14,722,264

   15,032,325

   14,659,590

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three and six months ended June 30, 2021
(unaudited)

	Common Stock					Accumulated
	Shares	Par Value		Paid-in Capital		Deficit		Total

Balance at December 31, 2020	14,855,792	$	1,486	$	3,189,140	$	(4,326,338)	$	(1,135,712)

Common stock sold	8,000		1		5,999		-		6,000
Common stock issued for services	58,287		6		29,862		-		29,868
Net loss	-		-		-		(137,325)		(137,325)
Balance at March 31, 2021	14,922,079		1,493		3,225,001		(4,463,663)		(1,237,169)

Common stock sold	49,020		4		24,996		-		25,000
Common stock issued for "anti- dilution" protection	39,844		4		(4)		-		-
Common stock issued for services	120,713		12		120,701		-		120,713
Net loss	-		-		-		(256,167)		(256,167)
Balance at June 30, 2021	15,131,656	$	1,513	$	3,370,694	$	(4,719,830)	$	(1,347,623)

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three and nine months ended September 30, 2021
(unaudited)

Common Stock

Accumulated

Shares

Par Value

Paid-in Capital

Deficit

Total

Balance at December 31, 2020
  14,855,792

$
        1,486

$
    3,189,140

$
  (4,326,338)

$
  (1,135,712)

Common stock sold
          8,000

              1

           5,999

               -

          6,000
Common stock issued for services
        58,287

              6

         29,862

               -

        29,868
Net loss
               -

             -

                -

     (137,325)

     (137,325)
Balance at March 31, 2021
  14,922,079

        1,493

    3,225,001

  (4,463,663)

  (1,237,169)

Common stock sold
        49,020

              4

         24,996

               -

        25,000
Common stock issued for "anti-dilution" protection
        39,844

              4

                (4)

               -

               -
Common stock issued for services
      120,713

            12

       120,701

               -

      120,713
Net loss
               -

             -

                -

     (256,167)

     (256,167)
Balance at June 30, 2021
  15,131,656

        1,513

    3,370,694

  (4,719,830)

  (1,347,623)

Common stock sold
      189,216

            19

         96,481

               -

        96,500
Common stock issued for Restricted Stock Award
      200,000

            20

              (20)

               -

               -
Stock-based compensation on RSA's vested
               -

             -

         25,500

               -

        25,500
Common stock issued for settlement of liabilities
        30,000

              3

         15,777

               -

        15,780
Common stock issued for services
        67,178

              7

         78,480

               -

        78,487
Net loss
               -

             -

                -

     (224,721)

     (224,721)
Balance at September 30, 2021
  15,618,050

$
        1,562

$
    3,586,912

$
  (4,944,551)

$
  (1,356,077)

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONSENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the six months ended June 30,
(unaudited)
	2022		2021

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(490,296)	$	(393,492)
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Depreciation and amortization		94		589
Stock issued for services		189,582		150,581
Stock-based compensation on RSA's vested		51,000		-
Changes in operating assets and liabilities:
Prepaid expenses		(60)		(2,332)
Accounts payable		10,294		7,496
Accrued legal fees		36,255		20,940
Accrued payroll and payroll taxes		92,073		92,070
Accrued liabilities		36,254		19,228
Deferred revenue		-		(3,000)
Accrued interest payable		6,400		4,139
Net cash used in operating activities		(68,404)		(103,781)

CASH FLOWS FROM INVESTING ACTIVITIES:		-		-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock		59,415		31,000
Proceeds from borrowings on Note Payable		7,620		50,000
Borrowings of related party debt and short-term advances		-		29,436
Repayment of related party debt and short-term advances		(2,411)		(5,023)
Net cash provided by financing activities		64,624		105,413

NET CHANGE IN CASH		(3,780)		1,632
CASH AT BEGINNING OF PERIOD		3,780		3,906
CASH AT END OF PERIOD	$	-	$	5,538

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	$	-	$	-
Income taxes	$	-	$	-

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for intangible asset	$	-	$	-
Disposal of property and equipment	$	-	$	2,292
Common stock issued for anti-dilution protection	$	-	$	4

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three and nine months ended September 30, 2020
(unaudited)

Common Stock

Subscription

Accumulated

Shares

Par Value

Paid-in Capital

Receivable

Deficit

Total

Balance at December 31, 2019
  14,497,843

$
        1,450

$
    2,841,608

$
          (2,001)

$
  (3,280,859)

$
     (439,802)

Subscription received
               -

             -

                -

            2,001

               -

          2,001
Common stock issued for services
        46,564

              5

         38,550

                 -

               -

        38,555
Common stock issued for intangible assets
      125,000

            13

       124,987

                 -

               -

      125,000
Net loss
               -

             -

                -

                 -

     (186,452)

     (186,452)
Balance at March 31, 2020
  14,669,407

        1,468

    3,005,145

                 -

  (3,467,311)

     (460,698)

Common stock sold
        50,000

              5

         37,495

                 -

               -

        37,500
Common stock issued for services
          2,857

             -

           2,857

                 -

               -

          2,857
Net loss
               -

             -

                -

                 -

     (127,559)

     (127,559)
Balance at June 30, 2020
  14,722,264

        1,473

    3,045,497

                 -

  (3,594,870)

     (547,900)

Common stock issued for services
        56,574

              6

         56,568

                 -

               -

        56,574
Net loss
               -

             -

                -

                 -

     (154,007)

     (154,007)
Balance at September 30, 2020
  14,778,838

$
        1,479

$
    3,102,065

$
                 -

$
  (3,748,877)

$
     (645,333)

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the nine months ended September 30,
(unaudited)

2021

2020

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss
$
       (618,213)

$
       (468,018)
Adjustments to reconcile net income (loss) to net cash
used by operating activities:

Depreciation and amortization

            883

         1,621
Common stock issued for services

     229,068

       97,986
Common stock issued for settlement of liabilities

       15,780

                -
Stock-based compensation on RSA's vested

       25,500

                -
Changes in operating assets and liabilities:

Accounts receivable

                   -

            7,594
Prepaid expenses

             (583)

                   -
Accounts payable

         4,981

            935
Accrued legal fees

       31,361

       86,156
Accrued payroll and payroll taxes

     138,106

     157,602
Accrued liabilities

       15,089

       33,236
Deferred revenue

        (3,000)

                -
Accrued interest payable

         6,996

         8,019
Net cash used in operating activities

       (154,032)

        (74,869)

CASH FLOWS FROM INVESTING ACTIVITIES:

                   -

                   -

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from sale of common stock

     127,500

       39,501
Proceeds from borrowings on Note Payable

       60,000

                -
Borrowings of related party debt and short-term advances

       31,546

       50,132
Repayment of related party debt and short-term advances

      (23,926)

      (21,214)
Net cash provided by financing activities

        195,120

          68,419

NET CHANGE IN CASH

          41,088

          (6,450)
CASH AT BEGINNING OF PERIOD

            3,906

            7,313
CASH AT END OF PERIOD
$
          44,994

$
              863

SUPPLEMENTAL DISCLOSURE OF CASH FLOW
INFORMATION:

Interest
$
            1,937

$
                   -
Income taxes
$
                   -

$
                   -

NON-CASH INVESTING AND FINANCING ACTIVITIES:

Common stock issued for intangible asset
$
                   -

$
        125,000

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~September~~June 30, ~~2021~~2022

(Unaudited)

NOTE 1 – ORGANIZATION AND OPERATIONS

Organization ~~and Current Operations~~

The Company was incorporated in June 2013 as Somerset Transition Corporation under the Oklahoma General Corporation Act. The Company was formed to complete a reorganization under Section 1088(g) of the Oklahoma Act, whereby the Company became successor to Transnational Financial Network, Inc., which was originally incorporated in California in 1985. In September 2013, the Company was redomesticated in Maryland and changed its name to Somerset Property, Inc. In July 2017, the Company was redomesticated in Nevada and changed its name to Revival, Inc. In June 2019, the Company changed its name to Farmhouse, Inc. to reflect its new business endeavors.

In August 2019, the Company acquired Farmhouse, Inc., a Washington corporation (“Farmhouse Washington”) as its wholly owned subsidiary (the “Acquisition”). Farmhouse Washington was formed in January 2014 and has developed a social network platform, “The ~~WeedClub Platform.~~WeedClub® Platform”. At the closing of the Acquisition, all of the issued and outstanding shares of common stock of Farmhouse Washington were exchanged for shares of common stock of the Company on a one-for-one basis. The financial statements of the Company are the continuation of Farmhouse Washington with the adjustment to reflect the capital structure of the Company.

Prior to the Acquisition, onin August 1, 2017, Farmhouse Washington formed Farmhouse DTLA, Inc. (“DTLA”) in California as a wholly owned subsidiary. On April 8, 2021, DTLA ~~has an agreement with~~was awarded a ~~medical marijuana growing and retail company based~~49% equity interest in a Los Angeles ~~which~~based multi-licensed cannabis retail dispensary, grow, manufacturer and distributor called Los Angeles Farmers, Inc. (“LAFI”). Although ownership percentages over 20% would typically be accounted for using the equity method, the Company is ~~subject~~accounting for this investment as an investment in equity securities due to ~~litigation.~~the Company not having significant influence over LAFI. The cost of this investment was expensed during the fiscal year ended December 31, 2017 and, due to uncertainties surrounding the value of LAFI and determining any award of back profits and interest, as well as the pending litigation, no value has been reflected in our unaudited interim condensed consolidated financial statements as of June 30, 2022. See Note 9.

Current Operations

The Company is a technology company with multiple cannabis related divisions and IP, including the WeedClub® Platform, a professional social network platform to the regulated cannabis industry, ~~that~~which enables cannabis and hemp professionals to connect, discover products and services and scale their businesses. Within the WeedClub® Platform, members utilize an increasing set of technology-based tools for discovering professional connections and information. The Company believes it has established itself as the trusted brand to connect the industry through the WeedClub® Platform and its @420 Twitter handle. ~~Through its wholly owned subsidiary, DTLA, the Company owns a 49% equity interest in a Los Angeles-based multi-licensed cannabis retail dispensary, grow, manufacturer and distributor.~~ The Company offers its WeedClub members group opportunities while advertising and consulting revenues are generated via the curated opportunities.

Going Concern and Management’s Plans

The accompanying unaudited interim condensed consolidated financial statements have been presented on the basis that the Company is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. For the ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, the Company had a net loss from operations of ~~$622,586,~~$465,152, consisting primarily of general and administrative

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

and legal and professional expenses. In addition, as of ~~September~~June 30, ~~2021,~~2022, the Company had stockholders’ deficit of ~~$1,356,077~~$1,761,542 and available cash on hand of ~~$44,994.~~zero. In view of these matters, recoverability of any asset amounts shown in the accompanying unaudited interim condensed consolidated financial statements is dependent upon the Company’s ability to expand operations and achieve profitability from its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company has financed its activities principally from the sale of its common stock and loans from Company officers. The Company intends on financing its future working capital needs from these sources until such time that funds provided by operations are sufficient to fund working capital requirements. Management believes that loans from Company officers and funds raised from the sale of its common stock will allow sufficient capital for operations and to continue as a going concern.

~~FARMHOUSE, INC. AND SUBSIDIARIES~~

~~NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~September 30, 2021~~

~~(Unaudited)~~

~~In April 2021,~~On February 1, 2022, the board of directors (“Board”) authorized an offering of up to ~~1,000,000~~294,118 shares of restricted common stock at ~~$.51~~$0.85 per share, providing proceeds of up to $250,000, to be offered and sold only to investors that qualify as “accredited investors” as that term is defined in Regulation D. For the ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, the Company sold ~~238,236~~69,900 shares of common stock under this offering for proceeds of ~~$121,500. This~~$59,415. The offering ~~was terminated~~expired on August ~~31, 2021.~~1, 2022. See Note 7.

Subsequent to June 30, 2022, the Company received cash proceeds totaling $390,000, including $225,000 of funding under a Litigation Funding Agreement and $165,000 of proceeds from the sale of its domain name “blunt.com.” See Note 12.

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies is presented to assist the reader in understanding and evaluating the Company’s unaudited interim condensed consolidated financial statements. These accounting policies conform to Generally Accepted Accounting Principles (“GAAP”) and have been consistently applied in the preparation of these unaudited interim condensed consolidated financial statements.

Principals of Consolidation

The unaudited interim condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries Farmhouse Washington and DTLA (together the “Company”). All material intercompany accounts, transactions, and earnings have been eliminated in the accompanying unaudited interim condensed consolidated financial statements.

Financial Statement Reclassification

Certain amounts from the prior year’s financial statements have been reclassified in these unaudited interim condensed consolidated financial statements to conform to the current year’s classifications.

Cash and Cash Equivalents

Cash and cash equivalents as of ~~September~~June 30, ~~2021~~2022 included cash in banks. The Company considers all highly liquid instruments with maturity dates within 90 days at the time of issuance to be cash equivalents.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

Basis of presentation

The accompanying unaudited interim condensed consolidated financial statements contained in this Report have been prepared in accordance with U.S. GAAP and the rules of the Securities and Exchange Commission (“SEC”) for interim financial information and do not include all of the information or disclosures required by U.S. GAAP for annual financial statements. Accordingly, these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K as of and for the year ended December 31, ~~2020,~~2021 filed with the Securities and Exchange Commission on April ~~30, 2021.~~22, 2022. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein.

Use of Estimates

Operating results for interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Significant estimates include the carrying value of property and equipment and intangible assets, grant date fair value of options, deferred tax assets and any related valuation allowance and related disclosure of contingent assets and liabilities. The Company evaluates its estimates, based

~~FARMHOUSE, INC. AND SUBSIDIARIES~~

~~NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~September 30, 2021~~

~~(Unaudited)~~

on historical experience and on various other assumptions that it believes to be reasonable under the circumstances. Actual results could materially differ from these estimates.

Revenue Recognition

In accordance with ASC No. 606, Revenue Recognition, the Company recognizes revenue from product sales or services rendered when the following five revenue recognition criteria are met: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation. The Company generates ~~five~~six types of revenue, including:

(1)Subscription fees. Subscription fees related to the WeedClub portal are received at the time of purchase. The Company’s performance obligation is to provide services over a fixed subscription period, accordingly, the Company recognizes revenue ratably over the subscription period and deferred revenue is recorded for the portion of the subscription period subsequent to each reporting date.

(1)(2)Affiliate advertising. Affiliate advertising revenues result from advertising campaigns and are generally multi-month arrangements. The Company’s performance obligation is met when the Company runs the agreed upon advertisements on its platform, accordingly, the Company recognizes revenue ratably over the campaign period and deferred revenue is recorded for the portion of the campaign period subsequent to each reporting date.

(2)(3)Event Sales. The Company collects payment up front for event ticket sales and sponsorships and records these payments as unearned revenue. The Company’s performance obligation is

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

met at the time the event takes place, accordingly, the Company recognizes revenue at the time the event takes place.

(3)(4)Referral fees. The Company generates referral fees when a business transaction is consummated between the Company, as referee, and a potential target company. The Company performance obligation is met at the time such business transaction is consummated, accordingly, the Company recognize revenue at that point.

(4)(5)Consulting and Other. The Company generates fees to assist presenting companies with request consulting services in connection with their investment deck and presentation scripts. Such consulting fees are recognized as services are performed.

(6)License revenues. The Company generates revenue from license fees in connection with NFT Art License Agreements, whereby the licensee is granted a limited license from the Company to use one of its licensed NFT’s for the purposes of creating, marketing, and selling a line of cannabis accessory products for retail sale in cannabis dispensaries. The Company’s performance obligation is met over the term of the license agreement, accordingly, the Company recognizes revenue ratably over the term of the license agreement.

Revenues generated for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 were as follows:

For the three months ended September 30,

For the nine months ended September 30,
2021

2020

2021

2020

(Unaudited)

(Unaudited)

(Unaudited)

(Unaudited)

Subscription fees
$
149

$
-

$
695

$
-
Affiliate advertising

-

-

8,850

-
Event Sales

-

-

-

2,940
Referral fees

-

5,000

2,500

5,000
Consulting and other

-

-

-

-
Total revenues
$
149

$
5,000

$
12,045

$
7,940

	Three months ended June 30,				Six months ended June 30,
	2022		2021		2022		2021
	(Unaudited)		(Unaudited)		(Unaudited)		(Unaudited)

Subscription fees	$	149	$	546	$	149	$	546
Affiliate advertising		-		-		-		8,850
Event Sales		-		-		-		-
Referral fees		-		-		-		2,500
Consulting and other		-		-		-		-
License revenues		2,500		-		2,500		-
Total revenues	$	2,649	$	546	$	2,649	$	11,896

NoThe corresponding costs of revenues ~~were incurred~~associated with affiliate advertising revenues was $8,000 for the ~~three and nine~~six months ended ~~September~~June 30, ~~2021 and 2020.~~2021.

Earnings (Loss) per Common Share

Net income (loss) per common share is computed pursuant to ASC 260-10-45, Earnings per Share – Overall – Other Presentation Matters. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net

~~FARMHOUSE, INC. AND SUBSIDIARIES~~

~~NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~September 30, 2021~~

~~(Unaudited)~~

income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that we incorporated as of the beginning of the first period presented.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

All dilutive common stock equivalents are reflected in our net income (loss) per share calculations. Anti-dilutive common stock equivalents are not included in our loss per share calculations. ~~The~~As of June 30, 2022 and December 31, 2021, the Company had one convertible note with a principal value of ~~$45,000 as of September 30, 2021 and December 31, 2020.~~$45,000. This note is convertible at a conversion price the note holder and the Company agree and therefore the number of shares it is convertible into is not determinable.

Recently Issued Accounting Pronouncements

There are no recently issued accounting pronouncements that the Company has not yet adopted that they believe are applicable or would have a material impact on the financial statements of the Company.

NOTE 3 – PROPERTY AND EQUIPMENT

Property and equipment is comprised of the following:

	September 30,		December 31,		June 30,		December 31,
	2021		2020		2022		2021
	(Unaudited)				(Unaudited)

Computer equipment	$	7,312	$	9,604	$	7,312	$	7,312
Less: Accumulated depreciation		(6,923)		(8,332)		(7,312)		(7,218)
	$	389	$	1,272	$	-	$	94

Depreciation is computed using the straight-line method based upon the estimated useful lives of the underlying assets, generally three years. Depreciation expense was ~~$883~~$94 and ~~$1,621~~$589 for the ~~nine~~six months ended ~~September~~June 30, 2022 and 2021, respectfully, and ~~2020,~~zero and $94 for the three months ended June 30, 2022 and 2021, respectfully.

~~FARMHOUSE, INC. AND SUBSIDIARIES~~

~~NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~September 30, 2021~~

~~(Unaudited)~~

NOTE 4 – CONVERTIBLE ~~NOTE~~NOTES PAYABLE

Convertible note payable is comprised of a ~~sole~~ promissory note to an unrelated individual in the amount of $45,000 as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively. Principal and interest was originally due on July 4, 2018 and is currently in default. The loan bears interest at 18% per annum, accrued monthly and is unsecured. Interest expense related to the convertible note payable was ~~$6,057 and $6,081~~$4,017 for each of the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020, respectively.~~2021. Accrued interest on the convertible note payable was ~~$34,153~~$40,212 and ~~$28,095~~$36,194 as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively.

The conversion feature was not accounted for under derivative accounting guidance because the settlement amount is not determinable by an underlying conversion price. Therefore, no derivative was recorded in these unaudited interim condensed consolidated financial statements as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020.~~2021.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

NOTE 5 – ~~NOTE~~SNOTES PAYABLE

Notes payable is comprised of the following:

	September 30,		December 31,		June 30,		December 31,
	2021		2020		2022		2021
	(Unaudited)				(Unaudited)

Borrowing under loan agreement, 6% per annum, personally guaranteed.	$	50,000	$	-	$	50,000	$	50,000
Note payable, 6% per annum, unsecured.		10,000		-		32,650		25,030
	$	60,000	$	-	$	82,650	$	75,030

On June 16, 2021, the Company entered into a loan agreement, not to exceed ~~$75,000.~~$75,000, with an ~~unaffiliate~~unaffiliated individual (“Lender”) and borrowed $50,000 as a first advance. This loan bears interest at 6% per annum, and is due nine months after the first advance, or such earlier date that the Lender may demand payment, which may not be earlier than 60 days after the first advance (“Maturity Date”). ~~At Lender’s sole discretion, the Maturity Date may be extended.~~ As of June 30, 2022, this loan is in default. Borrowings under this loan agreement shall remain senior with respect to priority lien and right of payment to any indebtedness acquired by the Company. As a condition of the loan agreement, the Company’s Chief Executive Officer personally and unconditionally guaranteed the timely repayment of the loan and is liable for any amounts remaining due and owed following the Maturity Date. Interest expense related to this borrowing was ~~$880~~$1,488 and $123 for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022 and 2021, respectively. Accrued interest on this borrowing was ~~$880~~$3,123 and $1,635 as of ~~September~~June 30, ~~2021.~~2022 and December 31, 2021, respectively.

On August 27, 2021, the Company borrowed $10,000 from an unrelated ~~individual.~~party. On December 15, 2021, the Company borrowed an additional $15,030 from the same party. These loans bear interest at 6% per annum and were due on April 30, 2022. As of June 30, 2022, these loans are in default. On March 2, 2022, the Company borrowed an additional $7,620 from the same party. This loan bears interest at 6% per annum and is due on ~~April~~September 30, 2022. Interest expense related to ~~this borrowing~~these borrowings was ~~$58~~$894 for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022. Accrued interest on ~~this borrowing~~these borrowings was ~~$58~~$1,135 and $241 as of ~~September~~June 30, ~~2021.~~

~~FARMHOUSE, INC. AND SUBSIDIARIES~~

~~NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~September~~2022 and December 31, 2021, respectively. Subsequent to June 30, ~~2021~~2022, the entire loan payable to this party totaling $32,650, together with accrued interest, was paid in full. See Note 12.

~~(Unaudited)~~

NOTE 6 – DUE TO RELATED PARTIES

Due to Related Parties ~~totals $157,985~~totaled $155,780 and ~~$150,365~~$158,191 as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively. These amounts are comprised of cash advances provided to the Company for operating expenses and direct payment of Company expenses by Company officers. For the ~~nine~~six months ended ~~September~~June 30, 2022, Company officers made no cash advances and were repaid $2,411. For the prior six months ended June 30, 2021, Company officers made cash advances of ~~$13,000, personally paid Company expenses of $18,546~~$29,436 and were repaid ~~$23,926. For the nine months ended September 30, 2020, Company officers made cash advances of $50,132 and were repaid $21,214.~~$5,023. The cash advances are non-interest bearing and are unsecured. Company officers own approximately ~~47.4%~~44.0% of the Company as of ~~September 30, 2021.~~the date of this report. The Company has agreed to indemnify Company officers for certain events or occurrences arising as a result of the officer or director serving in such capacity. See Note ~~10.~~11. Subsequent to June 30, 2022, Company officers were paid approximately $49,000 on their outstanding advances. See Note 12.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

NOTE 7 – STOCKHOLDERS’ DEFICIT

Authorized Capital

The Company’s authorized capital consists of 295,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of undesignated preferred stock, $0.0001 par value per share. The Board, in its sole discretion, may establish par value, divide the shares of preferred stock into series, and fix and determine the dividend rate, designations, preferences, privileges, and ratify the powers, if any, and determine the restrictions and qualifications of any series of preferred stock as established. Subsequent to June 30, 2022, the Board designated 500,000 of Series A 10% Cumulative Convertible Participating Preferred Stock. See Note 12.

Common Stock Offering

~~In April 2021,~~On February 1, 2022, the Board authorized an offering of up to ~~1,000,000~~294,118 shares of restricted common stock at ~~$0.51~~$0.85 per share, ~~(the “Offering Price”),~~ providing proceeds of up to ~~$510,000 (the “Offering”).~~$250,000, to be offered and sold only to investors that qualify as “accredited investors” as that term is defined in Regulation D. For the six months ended June 30, 2022, the Company sold 69,900 shares of common stock under this offering for proceeds of $59,415. The ~~Offering terminated~~offering expired on August 21, 2020. In connection with the Offering, the Board also approved a one-time, limited anti-dilution protection to certain investors who, in the last 12 months, invested at a per share price higher than the Offering Price.1, 2022.

Common stock transactions

A summary of the Company’s common stock transactions for the ~~nine~~six months ended ~~September~~June 30, 2022 is as follows:

·The Company sold 69,900 shares of common stock for cash proceeds of $59,415.

·The Company issued 193,500 shares of common stock for services rendered. The Company recorded an expense of $189,582 for the six months ended June 30, 2021 isbased on the closing price of the Company’s common stock on the OTCQB market.

As a result of these transactions, the Company has 15,957,950 shares of common stock outstanding as ~~follows:~~of June 30, 2022.

·The Company sold 8,000 shares of common stock for cash proceeds of $6,000.

·The Company issued ~~246,178~~179,000 shares of common stock for services rendered. The Company recorded an expense of ~~$229,068~~$150,581 for the ~~nine~~six months ended ~~September~~June 30, 2021 based on the closing price of the Company’s common stock on the OTC Pink market.

·The Company sold ~~238,236~~49,020 shares of common stock under the Common Stock Offering for proceeds of ~~$121,500. See “Common Stock Offering” above.~~$25,000 and issued this investor 17,255 shares of common stock for anti-dilution protection under the Offering.

·The Company issued 39,844 shares of common stock for anti-dilution protection to five investors who invested at a per share price higher than the Offering Price in the last 12 months. ~~See “Common Stock Offering” above.~~

·~~The Company issued 30,000 shares of common stock in settlement of $30,000 of liabilities and~~

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~September~~June 30, ~~2021~~2022

(Unaudited)

~~recognized a gain on extinguishment of debt in connection with this settlement. which is recorded as other income for the three and nine-month periods ended September 30, 2021.~~

·~~The Company granted a Restricted Stock Award of 200,000 shares of common stock under the Company’s 2021 Omnibus Incentive Plan to a Company office. See Note 8.~~

As a result of these transactions, the Company has ~~15,618,050~~15,131,656 shares of common stock outstanding as of ~~September~~June 30, 2021.

~~A summary of~~Subsequent to June 30, 2022, the ~~Company’s common stock transactions for the nine months ended September 30, 2020 is as follows:~~

·~~The Company sold 50,000~~Board issued 1,022,000 shares of common stock ~~for cash proceeds of $37,500.~~

·~~The~~as Restricted Stock Awards under its 2021 Omnibus Incentive Plan (see Note 8) to Company issued 105,995 shares of common stock for services rendered. The shares of common stock were valued at various prices, based on the closing price of the Company’s common stock on the OTC Pink market,officers, directors, and ~~resulted in an expense of $97,986 for the nine months ended September 30, 2020.~~

·The Company issued 125,000 shares of common stock for the acquisition of the domain blunt.com. The shares of common stock were valued at $125,000, based on the closing price of the Company’s common stock on the OTC Pink market.

~~As a result of these transactions, the Company has 14,778,838 shares of common stock outstanding as of September 30, 2020.~~

~~Subsequent to September 30, 2021, there were additional common stock transactions.~~consultants. See Note ~~11.~~12.

Shares Reserved

The Company is required to reserve and keep available of its authorized but unissued shares of common stock an amount sufficient to effect shares that could be issued in connection the conversion of the convertible note payable. See Note 4. This note is convertible at a conversion price that the noteholder and the Company agree upon, therefore the number of shares it is convertible into is not determinable. Accordingly, no shares of common stock are reserved for future issuance as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020.~~2021.

~~FARMHOUSE, INC. AND SUBSIDIARIES~~

~~NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~September 30, 2021~~

~~(Unaudited)~~

NOTE 8 – STOCK-BASED COMPENSATION

2021 Omnibus Incentive Plan

On May 12, 2021, the Board ~~and majority shareholders~~ approved the Farmhouse, Inc. Omnibus Incentive Plan (the “2021 OIP”). The 2021 OIP permits the granting of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units, Other Stock-Based Awards and Cash-Based Awards. The maximum number of shares of common stock that may be issued pursuant to Awards under the 2021 OIP is 3,000,000. Stockholders holding a majority of the Company’s common stock outstanding ~~signed a consent authorizing~~ratified the 2021 ~~OIP.~~OIP by written consent.

Any options to be granted under the 2021 OIP may be either “incentive stock options,” as defined in Section 422A of the Internal Revenue Code, or “non-statutory stock options,” subject to Section 83 of the Internal Revenue Code, at the discretion of the Board and as reflected in the terms of the written option agreement. The option price shall not be less than 100% of the fair market value of the optioned common stock on the date the option is granted. The option price shall not be less than 110% of the fair market value of the optioned common stock for an optionee holding at the time of grant, more than 10% of the total combined voting power of all classes of stock of the Company. Options become exercisable based on the discretion of the Board ~~of the Company~~ and must be exercised within ten years from the date of grant (five years from date of grant for Company employees and directors).

Any restricted stock awards to be granted under the 2021 OIP are issued and measured at fair market value on the date of grant and become vested in various monthly or quarterly installments from the date of grant, subject to the recipient remaining in the Company’s service on specified vesting dates. Vesting of restricted stock awards is based solely on time vesting. Stock-based compensation expense is recognized as the shares vest with a corresponding offset credited to additional paid-in-capital.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

Restricted Stock Awards

OnA summary of the Company’s non-vested restricted stock awards as of June 30, 2022 and changes for the six months then ended is presented below:

	Restricted Stock Awards		Weighted Average Grant Date Fair Value

Non-vested restricted stock awards, Dec. 31, 2021		150,000	$	1.02
Awarded		-
Vested		(50,000)		1.02
Forfeited		-
Non-vested restricted stock awards, June 30, 2022		100,000	$	1.02

In August ~~16,~~ 2021, the Board granted a Restricted Stock Award (“RSA”) of 200,000 shares of common stock under the 2021 OIP to ~~a Company officer.~~the Company’s CFO. The RSA shares vest 25,000 shares over each of the following eight fiscal quarters starting September 30, 2021. RSA shares are measured at fair market value on the date of grant and stock-based compensation expense is recognized as the shares vest with a corresponding offset credited to additional paid-in-capital. The Company recognized stock-based compensation expense of $51,000 on vested RSA shares for the six months ended June 30, 2022. Unrecognized stock-based compensation expense on the RSA shares was $102,000 as of June 30, 2022.

Subsequent to June 30, 2022, the Board granted additional RSA’s of 1,022,000 shares of common stock under the 2021 OIP to Company officers, directors, and consultants. See Note 12.

NOTE 9 – LITIGATION

In August 2017, the Company’s subsidiary, DTLA. entered into a Strategic Consulting Agreement (the “SCA”) with Absolute Herbal Pain Solutions, Inc., a medical marijuana growing, and retail company based in Los Angeles that now goes by the name Los Angeles Farmers, Inc. (“LAFI”). The SCA provided for DTLA to invest substantial sums of money into LAFI and also to provide management services for LAFI going forward. In exchange, LAFI agreed to provide DTLA with a share in any future profits and a 49% equity stake in LAFI. Following the SCA, in excess of $700,000 was spent by DTLA to stabilize LAFI’s finances and pay critical bills. In addition, DTLA brought in an outside management company with expertise in running grow and retail operations. Subsequent to DTLA providing funding and management resources to LAFI, DTLA and its management team were locked out of the LAFI facility in late October 2017.

On October 25, 2017, DTLA commenced litigation in Los Angeles County Superior Court (Case #BC681251) against LAFI and David and Irina Vayntrub, who were the sole officers, directors, and members of LAFI, seeking to enforce its contract rights under the SCA. On March 27, 2018, the litigation was stayed so that the parties could pursue the claims by way of arbitration at Judicate West. In January 2020, following more than a

~~FARMHOUSE, INC. AND SUBSIDIARIES~~

~~NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~September 30, 2021~~

~~(Unaudited)~~

year of discovery, DTLA entered into a confidential settlement with the Vayntrubs, however, the case continued against LAFI.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

In February 2021, a four-day arbitration hearing was held at Judicate West. On April 8, 2021, the ~~Judge~~Arbitrator overseeing the arbitration hearing issued a judgment in favor of DTLA and against LAFI (the “DLTA Judgment”). The DLTA Judgment awarded 49% of LAFI to DTLA as of the change of control in November 2017, along with a share of any profits from November 2017 to the present and going forward, accrued interest on those profits, and costs of bringing the litigation. The DLTA Judgment also appointed a ~~monitor,~~Monitor, to be supervised by the ~~Judge,~~Arbitrator, to determine how much in past profits and interest DTLA is entitled to be awarded and that DTLA is treated fairly by LAFI on a going forward basis. The impact of the DLTA Judgment has not been reflected in the accompanying unaudited interim condensed consolidated financial statements since the amount of the DLTA Judgment has not been determined. The Company is also reviewing the accounting treatment going forward.

Following the issuance of DTLA Judgment, DTLA filed a motion for reimbursement of costs in the amount of $22,382. No objection was filed by LAFI and on June 1, 2021, the amount was confirmed by the Los Angeles County Superior Court as a Judgment. In July 2021, DTLA received reimbursement costs in the amount of $22,382, which is recorded as other income for the ~~three~~year ended December 31, 2021.

Between July and ~~nine-month periods ended September 30, 2021. A court-appointed~~December 2021, the Monitor ~~is undertaking the~~undertook a detailed process ~~of determining~~to determine the value of the 49% of profits and proceeds from 2017 ~~forward~~to the present that DTLA is entitled to, in addition to the 10% prejudgment interest. The Monitor’s report ~~is expected~~was completed in January 2022. Based on the information in the Monitor’s report, DTLA has requested that the Arbitrator issue an award of back profits and interest and order the sale of LAFI to an independent third party in order to allow any judgment to be ~~completed~~paid to DTLA. An evidentiary hearing has been scheduled by the ~~end~~Arbitrator to commence on October 31, 2022 to determine what DTLA is owed. Accordingly, the impact of Q4the DLTA Judgment has not been reflected in the accompanying consolidated financial statements as of June 30, 2022.

On August 25, 2022, a receiver was appointed by the Los Angeles County Superior Court to assume control of LAFI. As the receiver was just appointed and has not had an opportunity to assume full control of LAFI, the impact of the appointment of the receiver is unknown at this time.

Subsequent to June 30, 2022, the Company received $225,000 of funding under a Litigation Funding Agreement with Legalist Fund III, LP. See Note 12.

NOTE 10 – RELATED PARTIES

As discussed in Note 6, cash advances are provided to the Company for operating expenses by Company officers, who were owed $155,780 and $158,191 by the Company as of June 30, 2022 and December 31, 2022, respectively. Company officers own approximately 44.0% of the Company as of the date of this report. The Company has agreed to indemnify Company officers for certain events or occurrences arising as a result of the officer or director serving in such capacity. See Note 11. Subsequent to June 30, 2022, Company officers were paid approximately $49,000 on their outstanding advances and the Board granted RSA’s of 400,000 shares of common stock under the 2021 OIP to Company officers. The RSA shares vest 25,000 shares over each of the following eight fiscal quarters starting September 30, 2022. See Note 12.

In February 2021, the Company entered into a CFO Consulting and Advisory Agreement with Lang Financial Services, Inc. (“LFSI”). In August 2021, the Board granted LFSI an RSA of 200,000 shares of common stock. The RSA shares vest 25,000 shares over each of the following eight fiscal quarters starting September 30, 2021. The Company recognized stock-based compensation expense of $51,000 on vested RSA shares for the six months ended June 30, 2022. Unrecognized stock-based compensation expense on the RSA shares was $102,000 as of June 30, 2022. Subsequent to June 30, 2022, the Board granted LFSI an

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

additional RSA of 200,000 shares of common stock under the 2021 OIP. These new RSA shares vest 25,000 shares over each of the following eight fiscal quarters starting September 30, 2022. See Note 12.

NOTE 1011 – COMMITMENTS AND CONTINGENCIES

In the normal course of its business, the Company may be subject to certain contractual obligations and litigation. In management’s opinion, upon consultation with legal counsel, there are no contractual obligations or current litigation that will materially affect the Company’s unaudited interim condensed consolidated financial position or results of operations.

Lease Commitment

The Company ~~leases~~leased desk space in an incubator in San Francisco, CA at the rate of $700 per desk. This lease was vacated in October 2021. The Company owes the property owner $8,050 as of June 30, 2022, which is ~~month-to-month with one calendar month written notice to terminate.~~included in accrued liabilities on the accompanying balance sheet.

Indemnification Agreements

The Company has agreed to indemnify its officers and directors for certain events or occurrences arising as a result of the officer or director serving in such capacity. The term of the indemnification period is for the officer’s or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company believes the estimated fair value of these indemnification agreements is minimal and no liability has been recorded as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020.~~2021.

NOTE 1112 – SUBSEQUENT EVENTS

As of August 29, 2022, the date of these unaudited interim condensed consolidated financial statements, there are no subsequent events that are required to be recorded or disclosed in the accompanying unaudited interim condensed consolidated financial statements other than those listed below and elsewhere in these unaudited interim condensed consolidated financial statements.

Litigation financing

On June 21, 2022, the Company executed a Litigation Funding Agreement with Legalist Fund III, LP, whereby Legalist will provide certain funding, in advance of any collection, in connection with certain claims that the Company has against LAFI. See Note 9. The terms of the Litigation Funding Agreement provide for committed funds of $325,000 with a first tranche of $225,000 and the second tranche of $100,000. With respect to the second tranche, the Company has the option of drawing down the $100,000 in a lump sum payment but is under no obligation to draw down the second tranche. On July 15, 2022, the Company received the first tranche of $225,000.

Upon collection of any claims in the LAFI litigation, Legalist’s recovery is 0.85 of the committed funds then in effect, if repayment in full prior to 12 months, and 0.27 of the committed funds then in effect for every additional four months, if repayment in full occurs thereafter. In addition, Legalist was granted a security interest on the assets of the Company.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~September~~June 30, ~~2021~~2022

(Unaudited)

~~Common stock transactions~~Sale of domain name

In June 2022, the Company received an unsolicited offer for its domain name “blunt.com” from an unaffiliated party. The Board considered this offer to be a fair arms-length price for a premium domain name and on July 20, 2022, the Company sold domain name “blunt.com” for $165,000, net of commission.

Payment of notes payable and officer loans

From the proceeds of the aforementioned funding events, the notes to an unrelated party totaling $32,650, together with accrued interest of $1,253, were paid in full (Note 5) and-, Company officers were paid approximately $49,000 on their outstanding advances (Note 6).

Restricted Stock Awards

On July 18, 2022, the Board granted Restricted Stock Awards (“RSAs”) totaling 1,022,000 shares of common stock under the 2021 OIP to Company officers, directors, and consultants. A summary of the Company’s non-vested restricted stock awards subsequent to June 30, 2022 is presented below:

	Restricted Stock Awards		Weighted Average Grant Date Fair Value

Non-vested restricted stock awards, June 30, 2022		100,000	$	1.020
Awarded – Company officers		400,000		0.190
Awarded – LFSI		200,000		0.190
Awarded – Company director		200,000		0.190
Awarded – Consultants		222,000		0.190
Vested		-		-
Forfeited		-
Non-vested restricted stock awards, August 29, 2022		1,122,000	$	0.264

The RSA shares to Company officers and LFSI vest 25,000 shares over each of the following eight fiscal quarters starting September 30, 2022. The RSA shares to Company director vest 100,000 upon grant, for past services rendered, and 25,000 shares over each of the following four fiscal quarters starting September 30, 2022. The RSA shares to consultants vest equally over each of the following four fiscal quarters starting September 30, 2022. RSA shares are measured at fair market value based on the closing price of the Company’s common stock ~~transactions subsequent~~on the OTCQB market on the date of grant ($0.19 per share on July 18, 2022). Stock-based compensation expense is recognized as the shares vest with a corresponding offset credited to ~~September~~additional paid-in-capital.

FARMHOUSE, INC. AND SUBSIDIARIES

NOTES TO QUARTERLY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, ~~2021 is as follows:~~2022

(Unaudited)

·Designation of Series A Preferred stock

On July 18, 2022, the Board designated 500,000 shares of the Company’s authorized preferred stock as Series A 10% Cumulative Convertible Participating Preferred Stock (the “Series A Preferred”). As of August 29, 2022, the date of these unaudited interim condensed consolidated financial statements were issued, no shares of Series A Preferred have been issued.

The Series A Preferred bears a 10% cumulative dividend and has a per share liquidation preference equal to $1.00 plus any unpaid dividends (“Liquidation Preference”). Dividends must be declared by the Board to become payable. If cash dividends were to be paid, the Series A Preferred would have preference in payment of dividends over the common stock and any other series of preferred stock later designated. Each dollar of Series A Preferred and any accumulated dividends are initially convertible into five shares of the Company’s common stock, or $.20 per share (the “Conversion Price”). The Conversion Price will be adjusted if there are dilutive issuances. Shares may be converted at any time at the election of the holders. There are no mandatory conversion provisions of the Series A Preferred. Starting one year after issuance, the Series A Preferred may be redeemed by the Company ~~issued 21,500~~upon 30 days notice, subject to prior conversion at any time.

Other attributes of the Series A Preferred are priority of class, anti-dilution protection, right of first refusal to the holders and voting rights on an as converted basis. The Series A Preferred is senior to all other classes of stock of the Company. In the event of liquidation, after the Preference Amount plus accrued dividends have been paid on all outstanding Series A Preferred, any remaining funds and assets of the Company legally available for distribution to the Shareholders will be distributed ratably among the Shareholders in accordance with their holdings on an as converted basis. The Series A Preferred is protected from a dilutive issuance of additional shares of stock at a per share less than the conversion price at the date of such new issuance. The Series A Preferred votes with the shares of common stock on an as-converted basis as a single class on all matters except for ~~services rendered.~~

~~As a result of these transactions,~~matters that affect the ~~Company has 15,639,550 shares of common stock outstanding as~~rights of the ~~date~~Series A Preferred, in which case the Series A Preferred votes separately as a single class. Holders of ~~this Report.~~Series A Preferred vote as a class to elect a single director out of a maximum of five directors.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

The following discussion should be read in conjunction with ~~the~~our interim condensed consolidated financial statements and related notes contained elsewhere in this Report, as well as our Annual Report on Form 10-K for the ~~fiscal~~ year ended December 31, ~~2020~~2021 as filed with the Securities and Exchange Commission (the “SEC”) on April ~~30, 2021.~~22, 2022. Certain statements made in this discussion are “forward-looking statements” within the meaning of 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based upon beliefs of, and information currently available to management as well as estimates and assumptions made by management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used herein, the words “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “future,” “intend,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors, including the risks relating to our business, industry, and our operations and results of ~~operations and the effects that the COVID-19 outbreak, or similar pandemics, could have on our business.~~operations. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. We have made estimates of the impact of COVID-19 within our financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. Actual results may differ from these estimates.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Our interim condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and

assumptions can affect the reported amounts of assets and liabilities as of the date of ~~the~~these interim condensed consolidated financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our interim condensed consolidated financial statements would be affected to the extent there are material differences between these estimates and actual results. The following discussion should be read in conjunction with our interim condensed consolidated financial statements and notes thereto appearing elsewhere in this Report.

Unless otherwise indicated or the context requires otherwise, the words “we,” “us,” “our,” the “Company,” “our Company” or “Farmhouse” refer to Farmhouse Inc., a Nevada corporation, and our wholly owned subsidiaries, Farmhouse, Inc., a Washington corporation (“Farmhouse Washington”) and Farmhouse DTLA, Inc. (“DTLA”), a California corporation.

Corporate Overview

On August 13, 2019, the Company consummated an Agreement and Plan of Merger with Farmhouse Washington which became a wholly owned subsidiary. On this date, all of the issued and outstanding shares of common stock of Farmhouse Washington were exchanged for shares of common stock of the Company on a one share for one share basis (the “Acquisition”). Upon consummation of the Acquisition, the financial statements are the continuation of Farmhouse Washington with the adjustment to reflect the capital structure of the Company.

We are a ~~holding company dedicated to connecting~~leading connection platform in the legal cannabis industry. We connect the industry through multiple divisions including ~~WeedClub,~~ the @420 brand and @420 Twitter, ~~handle~~ and the WeedClub® Platform. Our @420 brand and @420 Twitter serve as trusted, influential properties that enable the Company to connect, promote and advocate for the industry. These properties leverage the WeedClub® Platform to

drive valuable connections for cannabis startups and supplier connections for retail dispensaries. We will continue to serve as a ~~49% equity interest~~leading cannabis connection platform and branch its well-known brand into the budding web3 and metaverse. Every company needs Friends in ~~a Los Angeles-based multi-licensed cannabis retail dispensary, grow, manufacturer~~High Places® and ~~distributor.~~our multiple divisions to provide exactly that.

~~WeedClub® Platform: Our WeedClub® Platform is~~Recent Business Developments

In July 2021, we successfully enforced DTLA’s contract rights in an operating retail cannabis business in Los Angeles. After four years of litigation, a ~~professional social networking platform~~Final Judgment was filed into the record in the Superior Court of California in the County of Los Angeles for case number BC681251 (the “DTLA Judgment”). See “Farmhouse Divisions” below.

In October 2021, we uplisted from the ~~regulated~~OTC Pink Sheets to the OTCQB Venture Marketplace and commenced trading under the symbol “FMHS.” This marked a milestone for our Company by being recognized as a fully-reporting cannabis company and ~~hemp industries. It was founded~~increasing its reach to more retail and private investors.

In November 2021, we began exploring potential acquisitions of cannabis companies to expand our physical footprint in ~~2014 and has established a trusted brand by providing a private and secure way for members~~the industry. Acquisitions would improve our ability to ~~network with fellow industry stakeholders through~~leverage our WeedClub® Platform and ~~in-person and virtual events.~~

~~@420: Our signature brand encompasses~~ our @420 Twitter handle to connect with consumers. We have not entered into any serious discussions with potential target companies as of the date of this filing.

In December 2021, we launched a Non-Fungible Token (NFT) division dedicated to connecting the metaverse with cannabis brands. As a leader in technology, we established this division to bring NFTs to cannabis brands to create a symbiotic relationship between two fast-growing industries. Our NFT division explores how cannabis brands can connect with the metaverse through NFTs. It is a natural expansion of our brand and bridges the gap between physical cannabis brands and digital assets. Our NFT division is currently investigating initiatives from creating NFTs with artists, launching an NFT project, and developing NFT IP licensing opportunities with cannabis brands.

In April 2022, we entered into a joint venture to license Bored Ape Yacht Club #2186, “Oro Blanco,” as the face of a new cannabis brand on behalf of Ape-In Productions, a ground-breaking entertainment company, and virtual community. This was the first significant licensing agreement for our NFT division we launched in December 2021.

In May 2022, we entered into an agreement with Urbana to feature a Bored Ape Yacht Club #2186 cannabis strain on shelves at both their San Francisco dispensary locations. This represented our first partnership that placed our NFT IP on cannabis products in stores for people to purchase.

Farmhouse Divisions

Our @420 ~~pitch events.~~brand and Twitter handle (with over 97,000 followers) serve as an influential brand that connects us with the greater public. Our Twitter handle enables the ~~Company~~NFT division to ~~raise awareness, engage~~forge valuable connections in the space and work with and advertise to cannabis enthusiasts, businesses and consumers. With over 93,000 followers, our organic tweets consistently generate engagement rates of at least 2% and upwards of 10% while the industry average is 0.07% on Twitter according to Social Insider. In addition, our Twitter handle provides an approved paid advertising channel that many companies lack access to. This exclusive ability enables our members to drive traffic to their websites and deliver increased sales through approved paid advertising campaigns. The @420 pitch connects cannabis startups with investors in both in-person and virtual events. Our events have hosted over 100 startup pitches, led to more than $50M in funding raised and generated over 10 fully funded and exited startups.established projects.

~~LA Dispensary: In April 2021,~~The WeedClub® Platform is a premier networking platform with over 5,000 cannabis professionals and is the ~~Judge overseeing~~backbone of the Company. WeedClub® Platform is an ~~arbitration hearing~~established presence in the cannabis industry that people trust to make valuable connections. As we continue to expand our ~~ongoing lawsuit against a downtown Los Angeles retail dispensary issued a judgment in favor of DTLA. The judgment~~operations, WeedClub members benefit immensely from the added potential connections.

As discussed above, the DTLA Judgment awarded 49% of this dispensary to DTLA. In addition to equity ownership, the ~~judgment~~DTLA Judgment awarded DTLA a share of any profits of this dispensary from November 2017 to the present and going forward along with accrued interest on those profits and the costs of bringing

litigation. The ~~Court~~DLTA Judgment also appointed a ~~monitor,~~Monitor, to be supervised by the ~~Judge,~~Arbitrator, to determine how much in past profits and interest ~~we are~~DTLA is entitled to be awarded and ~~to ensure we are~~that DTLA is treated fairly by LAFI on a going-forward basis. Between July and December 2021, the ~~counterparty going forward. Currently, no impact~~Monitor undertook a detailed process to determine the value of the ~~Judgment~~49% of profits and proceeds from 2017 to the present that DTLA is entitled to, in addition to the 10% prejudgment interest. The Monitor’s report was completed in January 2022. Based on the information in the Monitor’s report, DTLA has requested that the Arbitrator issue an award of back profits and interest and order the sale of LAFI to an independent third party in order to allow any judgment to be paid to DTLA. That request will be heard by the Arbitrator in October 2022.

Although ownership percentages over 20% would typically be accounted for using the equity method, the Company is accounting for this investment as an investment in equity securities due to the Company not having significant influence over LAFI. The cost of this investment was expensed during the fiscal year ended December 31, 2017 and, due to uncertainties surrounding the value of LAFI and determining any award of back profits and interest, as well as the pending litigation, no value has been reflected in our ~~accompanying unaudited~~ interim condensed consolidated financial statements as of June 30, 2022. Reference is made to Note 9, Litigation, to the ~~amount of the Judgment has not been determined. See further discussion~~interim condensed consolidated financial statements included under ~~Part II,~~ Item ~~1. Legal Proceedings~~1 in this ~~report.~~

Our WeedClub® Platform, @420 Twitter handle and @420 pitch events provide essential services that position the Company as a trusted brand and connector within the cannabis industry. Our recent award of 49% equity ownership in the Los Angeles retail dispensary provides an additional asset for our holding company. With our strong brand and far-reaching cannabis network, we believe we are uniquely positioned to scale in the current political climate and in the event of federal legalization.

~~Our principal executive office is located at 1355 Market Street, Suite 488, San Francisco, CA 94103 and our phone number is (888) 420-6856.~~Report.

Current and Future Plan of Operations

Farmhouse is built on connection, brand, and trust. These three pillars establish the foundation that drives value for our community across all our divisions. Through technology, we leverage these pillars to connect members to value-add products, services, capital, and consumers. Our commitment to developing cannabis-specific technology solutions firmly established us as a trusted connector in the cannabis industry.

As our industry continues to grow, it faces the same problems due to the lack of federal legalization. For many cannabis brands, the lack of federal legalization leads to increased cost of expansion, lack of access to many proven digital marketing channels, and lack of access to capital and banking. We addressed these problems by being early movers by creating the WeedClub® Platform ~~a professional social networking platform,~~ and establishing the @420 brand including our @420 Twitter handle with over 93,000 followers.

Over the past ~~year,~~few years, new technology centered around a decentralized future (web3) has emerged as a potentially more effective solution for all the core problems our industry faces. Decentralization and web3 eliminate the walled gardens created by the platform economy that cannabis companies lack access to due to the lack of federal legalization. Through web3, cannabis brands can connect directly with their consumers, build community and raise capital through new channels to better position themselves for potential federal legalization.

The key feature of this decentralized future (web3)is ~~non-fungible tokens (NFTs).~~NFTs. What started out as simple digital JPEGs has rapidly evolved in the past year into curated ~~collectable~~collectible art and the digital proof of ownership that unlocks holder-specific value such as community, product and services discounts, and more.

Just as we were early movers when we created the WeedClub® Platform as a professional social network for the cannabis industry, we launched ~~Super Strains in October 2021, a~~our NFT ~~project~~

~~that connects~~division to connect cannabis brands directly to a community of cannabis and cryptocurrency enthusiasts. ~~Super Strains~~The NFT division is ~~a joint venture with a member~~an exploration of ~~the Bored Ape Yacht Club (BAYC) and a cybersecurity and smart contract auditor. This joint venture allows us to leverage~~how we can connect these two similar, rapidly growing industries.

The NFT division is our ~~connections in the cannabis industry and NFT communities to create a unique community ideal for cannabis brands to interact with.~~

~~Super Strains is the~~ first step that allows us to leverage our existing foundation to solve the problems of our industry through web3 solutions. As we build this new ~~crypto native,~~crypto-native, cannabis enthusiast community, we will drive brand awareness and access an entirely new demographic of members toof our ecosystem. Not only will this provide new opportunities for cannabis brands to engage with us, it will also expand our reach to younger demographics that care about engaging in a more instantaneous and genuine way.

We believe our entrance into web3 and NFTs adds a new layer ~~into~~to our current foundation and allows us to leverage what we have built to strengthen our ability to provide technological solutions that address the core problems our industry continues to face. We believe we are uniquely positioned to fill this industry need by scaling its commercial presence.

Liquidity and Capital Resources

Until such time we can raise additional capital or generate positive cash flow from operations, we will continue to be funded through short-term advances from the Company Officers. We estimate we will need $2,500,000 in capital, after satisfying our debt obligations, to cover our ongoing expenses and to successfully market and expand our product offerings. This is only an estimate and may change as we receive feedback from customers and have a better feel of the demand and revenues from our new products. Both of these factors may change and we may not be able to raise the necessary capital and if we are able to, that it may not be at favorable rates. We intend to meet our cash requirements for the next 12 months equity financing, debt financing, or other sources, which may result in further dilution in the equity ownership of our shares.

For the ~~nine~~six months ended ~~September~~June 30, 2021 and 2020, we generated revenues of $12,045 and $7,940, respectively, and we reported net losses of $618,213 and $468,018, respectively. We had negative cash flow from operating activities of $154,032 and $74,869, respectively. As of September 30, 2021,2022, we had ~~an accumulated deficit~~a net loss from operations of ~~$4,944,551~~$465,152, consisting primarily of general and aadministrative and legal and professional expenses. In addition, as of June 30, 2022, we had stockholders’ deficit of ~~$1,356,077.~~

$1,761,542 and available cash on hand of zero. Our auditors have raised substantial doubt regarding our ability to continue as a going concern ~~as a result~~because of our historical recurring losses and negative cash flows from operations as well as our dependence on private equity and financings. We anticipate that we will continue to report losses and negative cash flow. To date, we have financed our activities principally from the sale of common stock and loans from Company officers. We intend on financing our future working capital needs from these sources until such time that funds provided by our operations are sufficient to fund our working capital requirements. We believe that the loans from Company officers and funds raised from the sale of our common stock will allow us sufficient capital for operations and to continue as a going concern.

~~In April 2021, we~~On February 1, 2022, the board of directors (“Board”) authorized an offering of up to ~~1,000,000~~294,118 shares of restricted common stock at ~~$.51~~$0.85 per share, providing proceeds of up to ~~$510,000,~~$250,000, to be offered and sold only to investors that qualify as “accredited investors” as that term is defined in Regulation D. For the ~~nine~~six months ended ~~September~~June 30, ~~2021, we~~2022, the Company sold ~~238,236~~69,900 shares of common stock under this offering for proceeds of ~~$121,500.~~$59,415. This offering ~~was terminated~~expired on August ~~31, 2021.~~1, 2022.

Subsequent to June 30, 2022, we received cash proceeds totaling $390,000, including $225,000 from funding under a Litigation Funding Agreement and $165,000 from the sale of its domain name “blunt.com”. Reference is made to Note 12, Subsequent Events, to the interim condensed consolidated financial statements included under Item 1 in this Report.

Results of Operations

We generate six types of revenue:

·subscription fees consisting of membership dues,

·affiliate advertising from links within the web properties,

·ticket sales and sponsorships derived from events,

·referral fees from strategic business introductions,

·consulting fees, and

·License fees.

Each of the above segments is dependent on leads generated within the Farmhouse ecosystem. Subscription fees were billed based on the types of membership privileges that Members such as being able to communicate privately with dispensary owners and other licensed operators. Affiliate advertising revenue is derived from the placement of web links on WeedClub, @420 Twitter, e-mail and social media primarily. Live events by WeedClub and the @420 pitch by WeedClub, as well as community-building events such as mixers and topical panels, offer the Community unique sponsorship opportunities for signage, tables, and presentations. Sometimes Members require additional help to make professional connections and we charge a flat-rate consulting fee in these special situations. Lastly, we generate revenue from license fees in connection with NFT Art License Agreements, whereby the licensee is granted a limited license to use one of our licensed NFT’s for the purposes of creating, marketing, and selling a line of cannabis accessory products for retail sale in cannabis dispensaries.

Details regarding when each revenue stream is recognized are listed below:

(1)~~Nine~~Subscription fees. Subscription fees related to the WeedClub portal are received at the time of purchase. Our performance obligation is to provide services over a fixed subscription period; accordingly, we recognize revenue ratably over the subscription period and deferred revenue is recorded for the portion of the subscription period subsequent to each reporting date.

(2)Affiliate advertising. Affiliate advertising revenues result from advertising campaigns and are generally multi-month arrangements. Our performance obligation is met when we run the agreed upon advertisements on its platform, accordingly, we recognize revenue ratably over the campaign period and deferred revenue is recorded for the portion of the campaign period subsequent to each reporting date.

(3)Event Sales. We collect payment up front for event ticket sales and sponsorships and records these payments as unearned revenue. Our performance obligation is met at the time the event takes place; accordingly, we recognize revenue at the time the event takes place.

(4)Referral fees. We generate referral fees when a business transaction is consummated between the Company, as referee, and a potential target company. Our performance obligation is met at the time such business transaction is consummated, accordingly, we recognize revenue at that point.

(5)Consulting and Other. We generate fees to assist presenting companies with request consulting services in connection with their investment deck and presentation scripts. Such consulting fees are recognized as services are performed.

Six months ~~Ended September~~ended June 30, ~~2021,~~2022, compared to the ~~nine~~six months ~~Ended September~~ended June 30, ~~2020~~2021 (Unaudited)

~~For~~Revenues generated for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and 2020, we generated revenues of $12,045 and $7,940. We generate five types of revenue, which generally consist of fees from subscriptions, affiliate advertising, event sales, referrals and consulting. Our revenues for the nine months ended September 30, 2021 ~~and 2020~~ were as follows:

	Nine months Ended September 30,				Six months ended June 30,
	2021		2020		2022		2021

Subscription fees	$	695	$	-	$	149	$	546
Affiliate advertising		8,850		-		-		8,850
Event Sales		-		2,940		-		-
Referral fees		2,500		5,000		-		2,500
Consulting and other		-		-		-		-
License revenues						2,500		-
	$	12,045	$	7,940	$	2,649	$	11,896

InSubscription fees. We generated one new subscription for the six months ended June ~~we launched a new Membership Benefits Program under~~30, 2022 related to the WeedClub® Platform, where subscribers can connect to ‘exclusive deals’ on essential products and services necessary to scale their business. Our special pricing of $149 for an annual subscription makes access to our WeedClub® Platform available to all.WeedClub portal.

Affiliate advertising. Affiliate advertising, through our advertising deal with Twitter, generated $8,850 of revenues for the ~~nine~~prior six months ended ~~September~~June 30, 2021. ~~In 2020, we entered into~~We have an advertising deal with Twitter which provides us a revenue stream and growth opportunity due to our ability to post approved hemp social media ads. The corresponding costs of revenues associated with affiliate advertising revenues was $8,000.

Referral fees. We generate referral fees when a business transaction is consummated between us and the potential target company. Such business transactions generally arise from the connections with company presenters during @420 events of which none were held during the six months ended June 30, 2022. Accordingly, our revenues from referral fees declined from $2,500 to zero for the six months ended June 30, 2022.

License revenues. We recognized revenue for an up-front license fee in connection with an NFT Art License Agreement, whereby the licensee was granted a limited license from the Company to us use one of its licensed NFT’s for the purposes of creating, marketing, and selling a line of cannabis accessory products for retail sale in California dispensaries.

Operating expenses for the six months ended June 30, 2022 and 2021 were as follows:

	Six months ended June 30,
	2022		2021

General and administrative	$	213,914	$	193,971
Professional fees		253,793		191,436
Depreciation and amortization		94		589
	$	467,801	$	385,996

For the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020,~~2021, general and administrative expenses were ~~$286,204~~$213,914 and ~~$273,928,~~$193,971, respectively, an overall increase of approximately ~~$12,400.~~$20,000. Contributing factors to this increase were:

·~~public~~Outside consulting fees increased by approximately $26,100, all of which was in stock-based fees in the current six month period.

·Labor-related expenses increased by approximately $1,800. Labor-related expenses included recognizing approximately $36,400 in stock-based fees in the current six month period.

·Public company related costs, including OTC filing fees, press releases and transfer agent costs increased by approximately ~~$13,400,~~$8,000, due primarily in increased listing fee on the OTCQB market, and

·~~overall~~Overall other general and administrative expenses, ~~increased by approximately $27,300,~~including website development, dues and

·~~labor-related~~subscriptions, rent and office expenses and travel and entertainment decreased by approximately ~~$28,300. Labor-related expenses included recognizing approximately $61,100 in stock-based fees in the current nine-month period.~~$15,900 due to general budget constraints.

For the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020,~~2021, professional fees were ~~$347,544~~$253,793 and ~~$161,756,~~$191,436, respectively, an increase of approximately ~~$185,800.~~$62,400. Our professional fees for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 were comprised of the following:

	Nine months Ended September 30,				Six months ended June 30,
	2021		2020		2022		2021

Legal	$	88,976	$	55,475	$	33,210	$	60,206
Accounting and audit		127,430		78,122		116,473		73,456
Professional fees		93,034		28,159
Consulting fees		38,104		-
Other professional fees						104,110		57,774
	$	347,544	$	161,756	$	253,793	$	191,436

Legal. Legal expenses ~~increased overall~~decreased by approximately ~~$33,500~~$27,000 for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 compared to the ~~nine~~six months ended ~~September~~June 30, ~~2020.~~2021. Contributing factors to this ~~increase~~net decrease were:

·Legal fees to our ~~current~~corporate and securities counsel ~~fees increased~~firms decreased by approximately ~~$15,300,~~$3,100.

·fees incurred by Judicate West and Planet Depot related to our litigation against LAFI increased by approximately $70,400. Reference is made to Note 9, Litigation, to the Condensed Consolidated Financial Statements included under Item 1 in this Report,

·Legal fees to our patent and trademark counsel increased by approximately ~~$1,100, and~~$3,400.

·~~fees~~Fees incurred by Judicate West, Planet Depot and court reporting related to ~~litigation counsel in connection with~~ our litigation against LAFI decreased by approximately ~~$53,300.~~ $50,600, due to winding down of the active litigation.

·Our portion of the fees incurred by the Monitor to advance our litigation against LAFI were approximately $23,300 for the six months ended June 30, 2022. In April 2021, the Arbitrator overseeing the arbitration hearing issued a judgment in our favor and against LAFI. This

judgment also appointed a Monitor, to be supervised by the Arbitrator, to determine how much in past profits and interest we are entitled to be awarded. The costs of the Monitor are borne equally between the Company and LAFI. Between July and December 2021, the Monitor undertook a detailed forensic examination of LAFI. The Monitor’s report was completed in January 2022. Reference is made to Note 9, Litigation, to the interim condensed consolidated financial statements included under Item 1 in this Report.

Accounting and audit. Accounting and audit expenses increased by approximately ~~$49,300~~$43,000 for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022, compared to the ~~nine~~six months ended ~~September~~June 30, ~~2020.~~2021. Contributing factors to this increase were:

·Audit and accounting fees to our independent public accounting firm ~~increased~~decreased by approximately ~~$4,800 for~~$1,000 related to our annual fiscal year ~~audit and quarterly reviews,~~audit.

·Accounting fees for our contracted CFO services increased by approximately ~~$54,300,~~$40,700, which included ~~$60,800~~$51,500 in stock-based fees in the six months ended June 30, 2022 compared to $35,300 of stock-based fees recognized in the ~~current nine-month period, and~~six months ended June 30, 2021.

·Accounting fees to our outside bookkeeping services ~~decreased~~increased by approximately ~~$9,800 for the costs of filing our corporate federal income tax returns in the prior year comparable period.~~$3,300.

~~Professional~~Other professional fees. Other professional fees increased by approximately ~~$64,900~~$47,400 for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022, compared to the ~~nine~~six months ended ~~September~~June 30, ~~2020~~2021 due to an increase in fees to our contracted software engineers and developers of our software technology platforms. ~~Professional~~All professional fees ~~included recognizing approximately $92,000 in~~incurred for both the six months ended June 30, 2022 and 2021 were comprised of stock-based ~~fees in the current nine-month period.~~fees.

~~Consulting fees~~Interest expense increased by approximately ~~$38,100~~$5,800 for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 compared to the ~~nine~~six months ended ~~September~~June 30, ~~2020 due to an~~2021. Approximately $3,500 of the increase in ~~fees to an outside strategic business consultant. Consulting fees included recognizing approximately $38,100 in stock-based fees in the current nine-month period.~~

~~For the nine months ended September 30, 2021 and 2020~~ interest expense was ~~$32,229~~due to interest accrued on our unpaid liability to our predecessor law firm in the aforementioned litigation. This law firm resigned in April 2021 when we engaged a new “contingency-based” law firm and ~~$38,653, respectively, a decrease of approximately $6,400. Interest charged by our former litigation counsel~~started accruing interest expense on their unpaid ~~balance decreased by approximately $7,300 while~~amount. The additional increase in interest expense onof approximately $2,300 pertains to our ~~other debt~~two loan obligations ~~increased by approximately $900 in~~during the ~~current nine-month period.~~six months ended June 30, 2022.

Overall, for the ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, we reported a net loss of ~~$618,213~~$490,296 compared to a net loss of ~~$468,018~~$393,492 for the ~~nine~~six months ended ~~September~~June 30, ~~2020, an overall increase~~2021.

Non-GAAP Adjusted Net Loss

The following table reflects the reconciliation of ~~approximately $150,200 from~~net loss to Adjusted Net Loss for the ~~prior year comparable period. Not including stock-based fees recorded~~six months ended June 30, 2022 and 2021. This is a non-GAAP measurement of earnings and considers the stock-related compensation expense for services rendered by consultants and professionals ~~which totaled approximately $254,600 and $98,000~~ for the ~~nine months ended September 30, 2021~~comparable years. Management considers this non-GAAP measurement of earnings important to investors and ~~2020, respectively (as discussed above),~~other interested parties to evaluate the Company’s performance on a comparable basis.

	Six months ended June 30,
	2022		2021

Net loss as reported	$	490,296	$	393,492
Less: Stock-based fees		(240,582)		(150,581)
Adjusted Net Loss	$	249,714	$	242,911

Adjusted Net Loss should only be viewed in conjunction with our ~~net loss actually decreased by approximately $6,400 from the prior year comparable period, as shown~~reported financial results or other financial information prepared in accordance with accounting principles generally accepted in the ~~following table:~~United States, or “GAAP.”

Nine Months ended September 30,

2021

2020

Net loss
$
618,213

$
468,018
Less: Stock-based fees

254,568

97,986

$
363,645

$
370,032

Three ~~Months Ended September~~months ended June 30, ~~2021,~~2022, compared to the three ~~Months Ended September~~months ended June 30, ~~2020~~2021 (Unaudited)

Revenues generated for the three months ended June 30, 2022 and 2021 were as follows:

	Three months ended June 30,
	2022		2021

Subscription fees	$	149	$	546
Affiliate advertising		-		-
Event Sales		-		-
Referral fees		-		-
Consulting and other		-		-
License revenues		2,500		-
	$	2,649	$	546

Subscription fees. We generated one new subscription for the three months ended June 30, 2022 related to the WeedClub portal.

Operating expenses for the three months ended June 30, 2022 and 2021 were as follows:

	Three months ended June 30,
	2022		2021

General and administrative	$	121,328	$	120,623
Professional fees		128,064		124,310
Depreciation and amortization		-		295
	$	249,392	$	245,228

For the three months ended ~~September~~June 30, ~~2021~~2022 and 2020, we generated revenues of $149 and $5,000, respectively. We generate five types of revenue, which generally consist of fees from subscriptions, affiliate advertising, event sales, referrals and consulting. Our revenues for the three months ended September 30, 2021, ~~and 2020 were as follows:~~

Three Months ended September 30,

2021

2020

Subscription fees
$
149

$
-
Affiliate advertising

-

-
Event Sales

-

-
Referral fees

-

5,000
Consulting and other

-

-

$
149

$
5,000

In June, we launched a new Membership Benefits Program under the WeedClub® Platform, where subscribers can connect to ‘exclusive deals’ on essential products and services necessary to scale their business. Our special pricing of $149 for an annual subscription makes access to our WeedClub® Platform available to all. We generate referral fees when a business transaction is consummated between us and potential target company.

~~For the three months ended September 30, 2021 and 2020,~~ general and administrative expenses were ~~$116,234~~$121,328 and ~~$107,831,~~$120,623, respectively, an overall increase of approximately ~~$8,400.~~$700. Contributing factors to this increase were:

·~~public~~Outside consulting fees increased by approximately $8,500, all of which was in stock-based fees in the current three month period.

·Labor-related expenses decreased by approximately $2,700. Labor-related expenses included recognizing approximately $23,600 in stock-based fees in the current three month period.

·Public company related costs, including OTC filing fees, press releases and transfer agent costs increased by approximately ~~$10,800,~~$5,600, due primarily in increased listing fee on the OTCQB market, and

·~~overall~~Overall other general and administrative expenses, ~~increased by approximately $20,800,~~including website development, dues and

·~~labor-related~~subscriptions, rent and office expenses and travel and entertainment decreased by approximately ~~$23,200. Labor-related expenses included recognizing approximately $26,400 in stock-based fees in the current three-month period.~~$10,700 due to general budget constraints.

For the three months ended ~~September~~June 30, ~~2021~~2022 and ~~2020,~~2021, professional fees were ~~$132,107~~$128,064 and ~~$48,470,~~$124,310, respectively, an increase of approximately ~~$83,600.~~$3,800. Our professional fees for the three months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 were comprised of the following:

	Three Months ended September 30,				Three months ended June 30,
	2021		2020		2022		2021

Legal	$	28,770	$	15,736	$	6,680	$	32,540
Accounting and audit		53,972		19,018		54,534		37,528
Professional fees		35,261		13,716
Consulting fees		14,104		-
Other professional fees						66,850		54,242
	$	132,107	$	48,470	$	128,064	$	124,310

Legal. Legal expenses ~~increased overall~~decreased by approximately ~~$13,000~~$25,800 for the three months ended ~~September~~June 30, ~~2021~~2022 compared to the three months ended ~~September~~June 30, ~~2020.~~2021. Contributing factors to this ~~increase~~net decrease were:

·Legal fees to our ~~current~~corporate and securities counsel ~~fees increased~~firms decreased by approximately ~~$10,400,~~$1,800.

·fees incurred by Judicate West and Planet Depot related to our litigation against LAFI increased by approximately $16,700. Reference is made to Note 9, Litigation, to the Condensed Consolidated Financial Statements included under Item 1 in this Report,

·Legal fees to our patent and trademark counsel increased by approximately ~~$1,600, and~~$200.

·~~fees~~Fees incurred by Judicate West, Planet Depot and court reporting related to ~~litigation counsel in connection with~~ our litigation against LAFI decreased by approximately ~~$15,700.~~$24,200, due to winding down of the active litigation.

Accounting and audit. Accounting and audit expenses increased by approximately ~~$35,000~~$17,000 for the three months ended ~~September~~June 30, ~~2021~~2022, compared to the three months ended ~~September~~June 30, ~~2020.~~2021. Contributing factors to this increase were:

·Audit and accounting fees to our independent public accounting firm ~~decreased~~increased by approximately $2,000 ~~for~~related to our annual fiscal year ~~audit and quarterly reviews,~~audit.

·Accounting fees for our contracted CFO services increased by approximately ~~$37,500,~~$12,500, which included $25,500 in stock-based fees in the three months ended June 30, 2022 compared to $20,000 of stock-based fees recognized in the ~~current nine-month period, and~~three months ended June 30, 2021.

·Accounting fees to our outside bookkeeping services ~~decreased~~increased by approximately ~~$500.~~$2,500.

~~Professional~~Other professional fees. Other professional fees increased by approximately ~~$21,500~~$12,600 for the three months ended ~~September~~June 30, ~~2021~~2022, compared to the three months ended ~~September~~June 30, ~~2020~~2021 due to an increase in fees to our

contracted software engineers and developers of our software technology platforms. ~~Professional~~All professional fees ~~included recognizing approximately $35,300 in~~incurred for both the three months ended June 30, 2022 and 2021 were comprised of stock-based ~~fees in the current three-month period.~~fees.

~~Consulting fees increased $14,100~~Interest expense decreased by approximately $2,100 for the three months ended ~~September~~June 30, ~~2021~~2022 compared to the three months ended ~~September~~June 30, ~~2020 due~~2021. Approximately $3,300 of the decrease in interest expense was from interest accrued on our unpaid liability to our predecessor law firm in the aforementioned litigation. This law firm resigned in April 2021 when we engaged a new “contingency-based” law firm and started accruing interest expense on their unpaid amount. This decrease was offset by an increase in ~~fees to an outside strategic business consultant. Consulting fees included recognizing~~interest expense of approximately ~~$14,100 in stock-based fees in the current three-month period.~~

~~For~~$1,200 on our two loan obligations during the three months ended ~~September~~June 30, 2021 and 2020 interest expense was $12,836 and $2,309, respectively, a decrease of approximately $10,500. Interest charged by our former litigation counsel on their unpaid balance increased by approximately $10,000 while interest expense on our other debt obligations increased by approximately $500 in the current three-month period.2022.

Overall, for the three months ended ~~September~~June 30, ~~2021,~~2022, we reported a net loss of ~~$224,721~~$256,079 compared to a net loss of ~~$154,007~~$256,167 for the three months ended ~~September~~June 30, ~~2020, an overall increase~~2021.

Non-GAAP Adjusted Net Loss

The following table reflects the reconciliation of ~~approximately $70,700 from~~net loss to Adjusted Net Loss for the ~~prior year comparable period. Not including stock-based fees recorded~~three months ended June 30, 2022 and 2021. This is a non-GAAP measurement of earnings and considers the stock-related compensation expense for services rendered by consultants and professionals ~~which totaled approximately $104,000 and $56,574~~ for the ~~three months ended September 30, 2021~~comparable years. Management considers this non-GAAP measurement of earnings important to investors and ~~2020, respectively (as discussed above),~~other interested parties to evaluate the Company’s performance on a comparable basis.

	Three months ended June 30,
	2022		2021

Net loss as reported	$	256,079	$	256,167
Less: Stock-based fees		(145,670)		(120,713)
Adjusted Net Loss	$	110,409	$	135,454

Adjusted Net Loss should only be viewed in conjunction with our ~~net loss increased by approximately $23,300 from the prior year comparable period, as shown~~reported financial results or other financial information prepared in accordance with accounting principles generally accepted in the ~~following table:~~United States, or “GAAP.”

Three Months ended September 30,

2021

2020

Net loss
$
224,721

$
154,007
Less: Stock-based fees

103,987

56,574

$
120,734

$
97,433

Cash Flows

The following table summarizes the sources and uses of cash for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020,~~2021, respectively:

Nine months Ended September 30,

2021

2020

Net cash used in operating activities
$
(154,032)

$
(74,869)
Net cash used in investing activities

-

-
Net cash provided by financing activities

195,120

68,419
Net increase (decrease) in cash and cash equivalents
$
41,088

$
(6,450)

	Six months ended June 30,
	2022		2021

Net cash used in operating activities	$	(68,404)		(103,781)
Net cash used in investing activities		-		-
Net cash provided by financing activities		64,624		105,413
Net change in cash and cash equivalents	$	(3,780)	$	1,632

~~Nine~~Six months ~~Ended September~~ended June 30, ~~2021~~2022

Operating activities used ~~$154,032~~$68,404 of cash, primarily resulting from our net loss for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 of ~~$618,213,~~$490,296, offset by non-cash ~~stock issued~~stock-based compensation expense recorded for services rendered of ~~$229,068~~$189,582, non-cash stock-based compensation expense recorded for vested restricted stock awards of $51,000, and ~~to settle~~increases in liabilities across most categories: accrued legal fees, accrued payroll and other accrued liabilities. There was no use of ~~$15,780 (net~~cash for investing activities for the six months ended June 30, 2022. Financing activities provided $64,624 of ~~gain on settlement~~cash for the six months ended June 30, 2022, consisting of ~~debt~~$59,415 in proceeds from the sale of ~~$14,220)~~common stock, $7,620 of borrowings from an unrelated lender, offset by repayments of $2,411 of advances from officers.

Six months ended June 30, 2021

Operating activities used $103,781 of cash, primarily resulting from a net loss of $393,492, offset by non-cash stock-based compensation expense recorded for services rendered of $150,581, and increases in liabilities across all categories: accounts payable, accrued legal fees, accrued payroll and other accrued liabilities. There was no use of cash for investing activities for the ~~nine~~six months ended ~~September~~June 30, 2021. Financing activities provided ~~$195,120~~$105,413 of cash, ~~for the nine months ended September 30, 2021,~~ consisting of ~~$127,500~~$31,000 in proceeds from the sale of common stock, ~~and $60,000~~$50,000 of borrowings ~~on two loan obligations, one for $50,000 (senior)~~from an unrelated lender and ~~one for $10,000, from unrelated lenders. Borrowings under the $50,000 loan obligation shall remain senior with respect to priority lien and right~~$29,436 of payment to any indebtedness later acquired. As a condition of this loan agreement, our Company’s Chief Executive Officer personally and unconditionally guaranteed the timely repayment of the loan. In addition to these cash increases, short-term advances from ~~Company~~ officers, ~~net of repayments provided of $7,620 of cash for the nine months ended September 30, 2021.~~

~~Nine months Ended September 30, 2020~~

~~Operating activities used $74,869 of cash, primarily resulting from our net loss for the nine months ended September 30, 2020 of $468,018,~~ offset by ~~non-cash stock issued for services~~repayments of ~~$97,986 and increases in liabilities across all categories: accounts payable, accrued legal fees, accrued payroll and other accrued liabilities. There was no use~~$5,023 of cash for investing activities for the nine months ended September 30, 2020. Financing activities provided $68,419 of cash for the nine months ended September 30, 2020, consisting of $39,501 in proceeds from the sale of common stock and $28,918 of short-term advances from ~~Company officers, net of repayments, for the nine months ended September 30, 2020.~~officers.

Contractual Obligations

We qualify as a smaller reporting company, as defined by Item 10 of Regulation S-K and, thus, are not required to provide the information required by this Item.

Off Balance Sheet Arrangements

We are not currently a party to, or otherwise involved with, any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Cash and Cash Equivalents

We consider all highly liquid investments with an original maturity of ~~three~~six months or less when purchased to be cash equivalents. Cash and cash equivalents were ~~$44,994~~zero and ~~$3,906~~$3,780 as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively.

Critical Accounting Policies and Estimates

The preparation of our interim condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of ~~the~~these interim condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our accounting policies that are critical or most important to understanding our financial condition and results of operations and that require management to make the most difficult judgments are described in our Annual Report on Form 10-K for the year ended December 31, ~~2020,~~2021 as filed with the SEC on April ~~30, 2021.~~22, 2022. There have been no material changes in these critical accounting policies.

Recently Adopted Accounting Pronouncements

Reference is made to Note 2, Summary of Significant Accounting Policies, to the ~~Condensed Consolidated Financial Statements~~interim condensed consolidated financial statements included under Item 1 in this Report.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management carried out an evaluation under the supervision and with the participation of our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (“Exchange Act”). Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were not effective as of ~~September~~June 30, ~~2021.~~2022.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting subsequent to ~~September~~June 30, ~~2021,~~2022, which were identified in connection with our management’s evaluation

required by paragraph (d) of rules

13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations of the Effectiveness of Disclosure Controls and Internal Controls

Our management, including our Principal Executive Officer and Principal Financial Officer, does not expect that our disclosure controls and internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control.

The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II – OTHER INFORMATION

None.

ITEM 1. LEGAL PROCEEDINGS

From time to time, the Company may become subject to various legal proceedings that are incidental to the ordinary conduct of its business. Although the Company cannot accurately predict the amount of any liability that may ultimately arise with respect to any of these matters, it makes provision for potential liabilities when it deems them probable and reasonably estimable. These provisions are based on current information and legal advice and may be adjusted from time to time according to developments.

The Company is a party to legal proceedings by the Company’s subsidiary, Farmhouse DTLA.

In August 2017, ~~the Company’s~~our subsidiary, DTLA. entered into a Strategic Consulting Agreement (the “SCA”) with Absolute Herbal Pain Solutions, Inc., a medical marijuana growing and retail company based in Los Angeles that now goes by the name Los Angeles Farmers, Inc. (“LAFI”). The SCA provided for DTLA to invest substantial sums of money into LAFI and also to provide management services for LAFI going forward. In exchange, LAFI agreed to provide

DTLA with a share in any future profits and a 49% equity stake in LAFI. Following the SCA, in excess of $700,000 was spent by DTLA to stabilize LAFI’s finances and pay critical bills. In addition, DTLA brought in an outside management company with expertise in running grow and retail operations. Subsequent to DTLA providing funding and management resources to LAFI, DTLA and its management team were locked out of the LAFI facility in late October 2017.

On October 25, 2017, DTLA commenced litigation in Los Angeles County Superior Court (Case #BC681251) against LAFI and David and Irina Vayntrub, who were the sole officers, directors, and

members of LAFI, seeking to enforce its contract rights under the SCA. On March 27, 2018, the litigation was stayed so that the parties could pursue the claims by way of arbitration at Judicate West. In January 2020, following more than a year of discovery, DTLA entered into a confidential settlement with the Vayntrubs, however, the case continued against LAFI.

~~Following the issuance of DTLA Judgment, DTLA filed a motion for reimbursement of costs in the amount of $22,382. No objection was filed by LAFI~~Between July and ~~on June 1,~~December 2021, the ~~amount was confirmed by the Los Angeles County Superior Court as~~Monitor undertook a Judgment. In July 2021, DTLA received reimbursement costs in the amount of $22,382, which is recorded as other income for the three and nine-month periods ended September 30, 2021. A court-appointed Monitor is undertaking thedetailed process ~~of determining~~to determine the value of the 49% of profits and proceeds from 2017 ~~forward~~to the present that DTLA is entitled to, in addition to the 10% prejudgment interest. The Monitor’s report ~~is expected~~was completed in January 2022. Based on the information in the Monitor’s report, DTLA has requested that the Arbitrator issue an award of back profits and interest and order the sale of LAFI to an independent third party in order to allow any judgment to be ~~completed~~paid to DTLA. An evidentiary hearing has been scheduled by the ~~end~~Arbitrator to commence on October 31, 2022 to determine what DTLA is owed.. Accordingly, the impact of ~~Q4 2021.~~the DLTA Judgment has not been reflected in the accompanying consolidated financial statements as of June 30, 2022.

ITEM 1A. RISK FACTORS

The Company qualifies as a smaller reporting company, as defined by Item 10 of Regulation S-K and, thus, are not required to provide the information required by this Item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Common Stock ~~Offering~~Offerings

In April 2021, the Board authorized an offering of up to 1,000,000 shares of restricted common stock at $0.51 per share (the “Offering Price”), providing proceeds of up to $510,000 (the “Offering”). The Offering will be offered and sold only to investors that qualify as “accredited investors” as that term is defined in Regulation D. The Offering terminated on August 21, ~~2020.~~2021. In ~~connection with the Offering,~~addition, the Board ~~also~~

approved a one-time, limited ~~anti-dilution protection~~“anti-dilution protection” to certain investors who, in the last 12 months, have invested at a per share price higher than the Offering ~~Price.~~Price, provided such investors make a new minimum investment under the Offering.

On February 1, 2022, the Board authorized an offering of up to 294,118 shares of common stock at $0.85 per share, providing proceeds of up to $250,000, to be offered and sold only to investors that qualify as “accredited investors” as that term is defined in Regulation D. For the six months ended June 30, 2022, we sold 69,900 shares of common stock under this offering for proceeds of $59,415. This offering expired on August 1, 2022.

Unless otherwise indicated, all of the following sales or issuances of Company securities were conducted under the exemption from registration as provided under Section 4(2) of the Securities Act of 1933 (and also qualified for exemption under 4(5), formerly 4(6) of the Securities Act of 1933, except as noted below). All of the shares issued were issued in transactions not involving a public offering, are considered to be restricted stock as defined in Rule 144 promulgated under the Securities Act of 1933 and stock certificates issued with respect thereto bear legends to that effect.

Common Stock Issuances

A summary of the Company’s common stock transactions for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 is as follows:

·The Company sold 69,900 shares of common stock for cash proceeds of $59,415.

·The Company issued 193,500 shares of common stock for services rendered. The Company recorded an expense of $189,582 for the six months ended June 30, 2022 based on the closing price of the Company’s common stock on the OTCQB market.

As a result of these transactions, the Company has 15,957,950 shares of common stock outstanding as of June 30, 2022.

·The Company sold 8,000 shares of common stock for cash proceeds of $6,000.

·The Company issued 30,000 shares of common stock in settlement of $30,000 of liabilities and recognized a gain on extinguishment of debt in connection with this settlement. which is recorded as other income for the three and nine-month periods ended September 30, 2021.

·~~The Company granted a Restricted Stock Award of 200,000 shares of common stock under the Company’s 2021 Omnibus Incentive Plan to a Company office. See Note 8.~~

As a result of these transactions, the Company has ~~15,618,050~~15,131,656 shares of common stock outstanding as of ~~September~~June 30, 2021.

~~A summary of~~Subsequent to June 30, 2022, the ~~Company’s common stock transactions for the nine months ended September 30, 2020 is as follows:~~

·~~The Company sold 50,000~~Board issued 1,022,000 shares of common stock ~~for cash proceeds of $37,500.~~

·~~The~~as Restricted Stock Awards under its 2021 Omnibus Incentive Plan to Company ~~issued 105,995 shares of common stock for services rendered. The shares of common stock were valued at various prices, based on~~officers, directors, and consultants. Reference is made to Note 12, Subsequent Events, to the ~~closing price of the Company’s common stock on the OTC Pink market, and resulted~~interim condensed consolidated financial statements included under Item 1 in ~~an expense of $97,986 for the nine months ended September 30, 2020.~~

~~As a result of these transactions, the Company has 14,778,838 shares of common stock outstanding as of September 30, 2020.~~

~~A summary of the Company’s common stock transactions subsequent to September 30, 2021 is as follows:~~

·~~The Company issued 21,500 shares of common stock for services rendered.~~

~~As a result of these transactions, the Company has 15,639,550 shares of common stock outstanding as of the date of~~ this Report.

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

There have been no events which are required to be reported under this item.

ITEM 4.MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.OTHER INFORMATION

None.

ITEM 6.EXHIBITS

The exhibits required to be filed herewith by Item 601 of Regulation S-K, as described in the following index of exhibits, are attached hereto unless otherwise indicated as being incorporated by reference, as follows:

Exhibit Number		Description

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act. *

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act. *

~~32.2~~32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of ~~2002.~~2002. *

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, City of San Francisco, State of California, on ~~November 12, 2021.~~August 29, 2022.

By:~~/s/ Evan Horowitz~~

~~EVAN HOROWITZ~~

~~Chief Executive Officer, Director~~

/s/ Evan Horowitz

EVAN HOROWITZ

Chief Executive Officer, Director

Pursuant to the requirements of the Securities Act of 1933, this registrant statement has been signed by the following persons in the capacities and on the dates indicated.

By:	/s/ Evan Horowitz
	EVAN HOROWITZ
	Chief Executive Officer, Director


By:	/s/ Lanny R. Lang
	LANNY R. LANG
	Chief Financial Officer, Chief Accounting Officer
	(Principal Financial and Accounting Officer)

By:	/s/ Michael Landau
	MICHAEL LANDAU
	Chief Technology Officer, Treasurer, Director


By:	/s/ Scott Bostick
	SCOTT BOSTICK
	Director

By: ~~/s/ Evan Horowitz~~

~~EVAN HOROWITZ~~

~~Chief Executive Officer, Director~~ 38

By: ~~/s/ Lanny R. Lang~~

~~LANNY R. LANG~~

~~Chief Financial Officer, Chief Accounting Officer~~

~~(Principal Financial and Accounting Officer)~~

By: ~~/c/ Michael Landau~~

~~MICHAEL LANDAU~~

~~Chief Technology Officer, Treasurer, Director~~

By: ~~/s/ Scott Bostick~~

~~SCOTT BOSTICK~~

~~Director~~

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: ~~September~~June 30, ~~2021~~2022
or

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from: _____________ to _____________

NEVADA (NV)	333-238326	46-3321759
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

	Large accelerated filer [ ]		Accelerated filer [ ]
	Non-accelerated filer [ ]		Smaller reporting company ☒

FARMHOUSE, INC. AND SUBSIDIARY
CONSENSED CONSOLIDATED BALANCE SHEETS

	June 30,		December 31,
	2022		2021
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	-	$	3,780
Prepaid expenses		3,810		3,750
Total current assets		3,810		7,530

Property and equipment, net		-		94
Intangible assets		250		250
Total assets	$	4,060	$	7,874

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable, including bank overdraft of $158	$	19,794	$	9,500
Accrued legal fees		427,322		391,067
Accrued payroll and payroll taxes		853,536		761,463
Accrued liabilities		137,050		100,796
Accrued interest payable		44,470		38,070
Convertible notes payable		45,000		45,000
Notes payable		82,650		75,030
Due to related parties		155,780		158,191
Total current liabilities		1,765,602		1,579,117

Stockholders’ deficit:
Preferred stock; $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding		-		-
Common stock; $0.0001 par value, 295,000,000 shares authorized, 15,957,950 and 15,694,550 shares issued and outstanding, respectively		1,596		1,570
Additional paid-in capital		4,029,075		3,729,104
Accumulated deficit		(5,792,213)		(5,301,917)
Total stockholders’ deficit		(1,761,542)		(1,571,243)
Total liabilities and stockholders’ deficit	$	4,060	$	7,874

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30,		December 31,
	2021		2020
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	44,994	$	3,906
Prepaid expenses		583		-
Total current assets		45,577		3,906

Property and equipment, net		389		1,272
Total assets	$	45,966	$	5,178

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	15,952	$	10,971
Accrued legal fees		298,488		267,127
Accrued payroll and payroll taxes		715,427		577,321
Accrued liabilities		74,100		59,011
Deferred revenue		-		3,000
Accrued interest payable		35,091		28,095
Convertible note payable		45,000		45,000
Notes Payable		60,000		-
Due to related parties		157,985		150,365
Total current liabilities		1,402,043		1,140,890

Stockholders’ deficit:
Preferred stock - Undesignated: $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding				-
Common stock, $0.0001 par value; 295,000,000 shares authorized, 15,618,050 and 14,855,792 shares issued and outstanding, respectively		1,562		1,486
Additional paid-in capital		3,586,912		3,189,140
Accumulated deficit		(4,944,551)		(4,326,338)
Total stockholders’ deficit		(1,356,077)		(1,135,712)
Total liabilities and stockholders’ deficit	$	45,966	$	5,178

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

	For the three months ended June 30,				For the six months ended June 30,
	2022		2021		2022		2021

REVENUES
Net revenues	$	2,649	$	546	$	2,649	$	11,896
Total revenues		2,649		546		2,649		11,896

OPERATING EXPENSES
General and administrative		121,328		120,623		213,914		193,971
Professional fees		128,064		124,310		253,793		191,436
Depreciation and amortization		-		295		94		589
Total operating expenses		249,392		245,228		467,801		385,996

LOSS FROM OPERATIONS		(246,743)		(244,682)		(465,152)		(374,100)

OTHER INCOME (EXPENSE):
Interest expense		(9,336)		(11,485)		(25,144)		(19,392)
Total other income (expense)		(9,336)		(11,485)		(25,144)		(19,392)

NET LOSS	$	(256,079)	$	(256,167)	$	(490,296)	$	(393,492)

BASIC AND DILUTED NET LOSS PER SHARE	$	(0.02)	$	(0.02)	$	(0.03)	$	(0.03)

BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		15,892,784		14,998,382		15,905,636		14,938,674

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three and nine months ended September 30, 2021
(unaudited)

	Common Stock					Accumulated
	Shares	Par Value		Paid-in Capital		Deficit		Total

Balance at December 31, 2020	14,855,792	$	1,486	$	3,189,140	$	(4,326,338)	$	(1,135,712)

Common stock sold	8,000		1		5,999		-		6,000
Common stock issued for services	58,287		6		29,862		-		29,868
Net loss	-		-		-		(137,325)		(137,325)
Balance at March 31, 2021	14,922,079		1,493		3,225,001		(4,463,663)		(1,237,169)

Common stock sold	49,020		4		24,996		-		25,000
Common stock issued for "anti-dilution" protection	39,844		4		(4)		-		-
Common stock issued for services	120,713		12		120,701		-		120,713
Net loss	-		-		-		(256,167)		(256,167)
Balance at June 30, 2021	15,131,656		1,513		3,370,694		(4,719,830)		(1,347,623)

Common stock sold	189,216		19		96,481		-		96,500
Common stock issued for Restricted Stock Award	200,000		20		(20)		-		-
Stock-based compensation on RSA's vested	-		-		25,500		-		25,500
Common stock issued for settlement of liabilities	30,000		3		15,777		-		15,780
Common stock issued for services	67,178		7		78,480		-		78,487
Net loss	-		-		-		(224,721)		(224,721)
Balance at September 30, 2021	15,618,050	$	1,562	$	3,586,912	$	(4,944,551)	$	(1,356,077)

The accompanying notes are an integral part of these condensed consolidated financial statements

FARMHOUSE, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the nine months ended September 30,
(unaudited)

	2021		2020

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(618,213)	$	(468,018)
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Depreciation and amortization		883		1,621
Common stock issued for services		229,068		97,986
Common stock issued for settlement of liabilities		15,780		-
Stock-based compensation on RSA's vested		25,500		-
Changes in operating assets and liabilities:
Accounts receivable		-		7,594
Prepaid expenses		(583)		-
Accounts payable		4,981		935
Accrued legal fees		31,361		86,156
Accrued payroll and payroll taxes		138,106		157,602
Accrued liabilities		15,089		33,236
Deferred revenue		(3,000)		-
Accrued interest payable		6,996		8,019
Net cash used in operating activities		(154,032)		(74,869)

CASH FLOWS FROM INVESTING ACTIVITIES:		-		-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock		127,500		39,501
Proceeds from borrowings on Note Payable		60,000		-
Borrowings of related party debt and short-term advances		31,546		50,132
Repayment of related party debt and short-term advances		(23,926)		(21,214)
Net cash provided by financing activities		195,120		68,419

NET CHANGE IN CASH		41,088		(6,450)
CASH AT BEGINNING OF PERIOD		3,906		7,313
CASH AT END OF PERIOD	$	44,994	$	863

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	$	1,937	$	-
Income taxes	$	-	$	-

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for intangible asset	$	-	$	125,000

The accompanying notes are an integral part of these condensed consolidated financial statements